Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Par Drugs & Chemicals Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 1 October 2026, 9:08 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price124₹ per share
Reported P/E10.5Times
Book value per share91.0₹ per share
Reported ROCE14.6 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 1 October 2026, 9:08 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap153 Cr.
Current Price124
High / Low180/78.0
Stock P/E10.5
Book Value91.0
Dividend Yield0.00 %
ROCE14.6 %
ROE9.95 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Par Drugs & Chemicals Ltd 153 Cr. 124 180/78.010.5 91.00.00 %14.6 %9.95 % 10.0
Auro Laboratories Ltd 152 Cr. 244 317/15931.7 74.40.00 %9.52 %8.49 % 10.0
Krebs Biochemicals & Industries Ltd 147 Cr. 68.0 76.8/38.3 75.50.00 %15.4 %Not available 10.0
Brooks Laboratories Ltd 161 Cr. 54.8 138/36.312.2 41.60.00 %21.2 %22.0 % 10.0
Achyut Healthcare Ltd 143 Cr. 5.91 10.0/4.70446 1.450.00 %1.18 %0.96 % 1.00
Industry Average17,573.63 Cr1,250.1655.08211.240.39%26.16%16.59%6.06

All Competitor Stocks of Par Drugs & Chemicals Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 22.9325.8924.0022.8222.6134.6621.3822.3326.0528.6629.3419.6131.28
Expenses 18.7918.5318.7716.7218.3723.2519.9519.9022.4922.6023.2918.1724.91
Operating Profit 4.147.365.236.104.2411.411.432.433.566.066.051.446.37
OPM % 18.05%28.43%21.79%26.73%18.75%32.92%6.69%10.88%13.67%21.14%20.62%7.34%20.36%
Other Income 0.010.050.23-0.050.071.020.270.791.840.481.330.360.94
Interest 0.020.030.020.050.020.030.010.020.020.050.010.040.02
Depreciation 0.830.850.870.890.900.910.910.920.900.940.930.930.96
Profit before tax 3.306.534.575.113.3911.490.782.284.485.556.440.836.33
Tax % 25.15%25.27%25.16%27.20%25.07%25.15%24.36%27.63%25.67%25.59%25.47%-3.61%25.59%
Net Profit 2.474.893.423.722.538.600.581.653.334.134.800.854.71
EPS in Rs 2.013.972.783.022.066.990.471.342.713.363.900.693.83

Last Updated: September 29, 2026, 6:31 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 7:52 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 2733334942465661759696101104109
Expenses 2026264034384645597873818789
Operating Profit 777888916161823201720
OPM % 27%22%22%17%19%18%17%26%22%19%24%19%17%18%
Other Income 00000002000243
Interest 44422211000000
Depreciation 22333333333444
Profit before tax 111333615131520181719
Tax % 40%27%58%42%42%24%21%21%27%25%26%26%24%
Net Profit 11022351291114131314
EPS in Rs 1.331.650.783.432.782.793.879.447.499.2111.7810.8610.6511.78
Dividend Payout % 0%0%0%0%0%0%32%0%0%0%0%0%0%

YoY Net Profit Growth

Year2014-20152015-20162017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)0.00%-100.00%0.00%50.00%66.67%140.00%-25.00%22.22%27.27%-7.14%0.00%
Change in YoY Net Profit Growth (%)0.00%-100.00%100.00%50.00%16.67%73.33%-165.00%47.22%5.05%-34.42%7.14%

Par Drugs & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:13%
3 Years:10%
TTM:10%
Compounded Profit Growth
10 Years:31%
5 Years:23%
3 Years:13%
TTM:-3%
Stock Price CAGR
10 Years:Not available
5 Years:33%
3 Years:-17%
1 Year:-58%
Return on Equity
10 Years:16%
5 Years:17%
3 Years:17%
Last Year:14%

Last Updated: September 5, 2025, 12:05 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: July 13, 2026, 3:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 33334661212121212
Reserves 99111225344648597387100
Borrowings 38363129126800000
Other Liabilities 91012101113161918162017
Total Liabilities 595856545160767989102119129
Fixed Assets 454342393634303438413936
CWIP 000001500001
Investments 00000000002527
Other Assets 131514151525424450605565
Total Assets 595856545160767989102119129
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 97942812813201616
Cash from Investing Activity + -0-0-2-1-0-10-3-7-6-25-2
Cash from Financing Activity + -9-5-8-4-212-100000
Net Cash Flow -11-10-0714-5614-914
Free Cash Flow 9674261246141514
CFO/OP 127%91%116%59%34%90%98%66%97%108%106%125%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow9.006.007.004.002.006.0012.004.006.0014.0015.0014.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1048381617567817590655260
Inventory Days 129111158698381455060494558
Days Payable 17118418313510794961121357358104
Cash Conversion Cycle 621057-55155301314404015
Working Capital Days 1026166-46-2613392461504039
ROCE %10%9%12%11%12%16%25%22%23%25%18%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 74.21%74.21%74.21%74.21%73.37%73.37%73.37%73.37%73.37%73.41%73.41%73.41%
FIIs 0.00%0.07%0.07%0.32%0.09%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DIIs 0.00%0.00%0.05%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.09%
Public 25.79%25.73%25.68%25.47%26.54%26.63%26.63%26.63%26.63%26.59%26.59%26.51%
No. of Shareholders 5,9027,0207,4038,0228,75717,18915,47214,88714,28013,76113,22212,782

This stock is not held by any mutual fund.

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 10.8611.789.217.4918.87
Diluted EPS (Rs.) 10.8611.789.217.4918.87
Cash EPS (Rs.) 13.8214.5811.8410.1523.45
Book Value[Excl.RevalReserv]/Share (Rs.) 80.4469.5957.9048.6684.87
Book Value[Incl.RevalReserv]/Share (Rs.) 80.4469.5957.9048.6684.87
Dividend / Share (Rs.) 0.000.000.001.250.00
Revenue From Operations / Share (Rs.) 82.0677.7377.8161.0198.75
PBDIT / Share (Rs.) 17.6018.7414.9913.3626.34
PBIT / Share (Rs.) 14.6315.9512.3610.6921.75
PBT / Share (Rs.) 14.5715.8612.2510.3220.71
Net Profit / Share (Rs.) 10.8611.799.217.4918.87
PBDIT Margin (%) 21.4424.1119.2621.8926.66
PBIT Margin (%) 17.8320.5115.8817.5222.02
PBT Margin (%) 17.7520.4015.7416.9220.97
Net Profit Margin (%) 13.2215.1611.8312.2719.11
Return on Networth / Equity (%) 13.4916.9315.9115.3822.23
Return on Capital Employeed (%) 17.5122.0020.3120.6122.15
Return On Assets (%) 11.1814.2712.7511.7015.20
Long Term Debt / Equity (X) 0.000.000.000.000.08
Total Debt / Equity (X) 0.000.000.000.000.14
Asset Turnover Ratio (%) 0.911.001.140.960.89
Current Ratio (X) 3.314.793.532.932.58
Quick Ratio (X) 2.944.463.152.612.39
Inventory Turnover Ratio (X) 19.646.978.137.687.47
Dividend Payout Ratio (NP) (%) 0.000.000.0016.690.00
Dividend Payout Ratio (CP) (%) 0.000.000.0012.310.00
Earning Retention Ratio (%) 0.000.000.0083.310.00
Cash Earning Retention Ratio (%) 0.000.000.0087.690.00
Interest Coverage Ratio (X) 263.72215.31138.4836.1925.22
Interest Coverage Ratio (Post Tax) (X) 163.70136.4086.0921.2815.99
Enterprise Value (Cr.) 76.93228.45150.02180.3662.64
EV / Net Operating Revenue (X) 0.762.391.572.401.03
EV / EBITDA (X) 3.559.918.1310.973.87
MarketCap / Net Operating Revenue (X) 1.032.771.802.621.25
Retention Ratios (%) 0.000.000.0083.300.00
Price / BV (X) 1.063.102.423.281.46
Price / Net Operating Revenue (X) 1.032.771.802.621.25
EarningsYield 0.120.050.060.040.15
Advertisements
Explore Industry-wise Company financial data